首页 > 最新文献

World journal of colorectal surgery最新文献

英文 中文
Right versus left Colon cancer: Is there a difference in outcomes? 癌症结肠癌与左结肠癌:结果有差异吗?
Pub Date : 2019-01-01 DOI: 10.4103/WJCS.WJCS_31_18
A. Plastiras, E. Iosif, G. Georgiou, A. Haji, Asif I Haq, S. Papagrigoriadis, J. Nunoo-Mensah
Background: Colorectal cancer is a major healthcare problem due to its high prevalence and mortality rates. Objective: The objective of the study is to delineate the relationship between the location of the colon cancer and the outcomes. Design: This is a retrospective, single-center study including patients diagnosed with right and left colon cancer from January 2010 to December 2015. Setting: Patients with no rectal or synchronous metastatic disease were included in the study. Diagnosis was confirmed following a computed tomography and colonoscopy. Patients and Methods: Four hundred and seventy-five patients with colon cancer were included; 226 right-sided tumors (RCC) and 249 with left-sided colon cancer (LCC) underwent surgery. Main Outcome Measures: We compared right- and left-sided tumors in terms of epidemiological, histological, clinical, and perioperative characteristics, and we also attempted to determine whether there is a difference in the overall and per stage survival. Sample Size: Four hundred and seventy-five patients with colon cancer. Results: Patients with colon cancer were analyzed, 226 (47.5%) with RCC and 249 (52.4%) with LCC underwent surgery. Patients with RCC were more likely to be women, older, and with more comorbidities. Furthermore, RCC were more likely to be poorly differentiated (29.65%, P < 0.001) and more locally advanced at the time of diagnosis (P < 0.001). Controlling the differentiation for each stage, there was no statistical significant difference between left and right survival and recurrence (P > 0.05). When stratified according to tumor stage, Stage II LCC had better overall survival (odds ratio [OR], 1.694, 95% confidence interval [CI], 1.015, 2.827) and Stage III LCC had a better overall survival (OR, 1.403, 95% CI, 1.007, 2.143), disease-free survival (OR, 1.293, 95% CI, 1.011, 1.714), and less cancer-related deaths (OR, 0.282, 95% CI, 0.080, 1.000). Conclusions: Comparing similar stages, patients with LCC appear to have better oncological outcomes irrespective of tumor differentiation. Limitations: Single-center, retrospective study without excluding patients with hereditary cancers. Oncological biomarkers were not available in all patients, and further analysis was not performed.
背景:癌症是一个主要的医疗保健问题,因为它的高发病率和死亡率。目的:探讨癌症发生部位与预后的关系。设计:这是一项回顾性的单中心研究,包括2010年1月至2015年12月诊断为癌症的患者。背景:没有直肠或同步转移性疾病的患者被纳入研究。诊断是在计算机断层扫描和结肠镜检查后确认的。患者和方法:包括475例癌症患者;226例右侧肿瘤(RCC)和249例左侧结肠癌(LCC)接受了手术。主要结果指标:我们比较了右侧和左侧肿瘤的流行病学、组织学、临床和围手术期特征,并试图确定总生存率和分期生存率是否存在差异。样本量:四百七十五名癌症结肠癌患者。结果:对癌症患者进行了分析,其中肾细胞癌226例(47.5%),LCC 249例(52.4%)进行了手术治疗。肾细胞癌患者更有可能是女性、老年人和更多合并症。此外,RCC在诊断时更可能是低分化的(29.65%,P<0.001)和更局部的晚期(P<0.001)。控制每个阶段的分化,左右存活率和复发率之间没有统计学上的显著差异(P>0.05),II期LCC具有更好的总生存率(比值比[OR],1.694,95%可信区间[CI],1.015,2.827),III期LCC具有较好的总生存期(OR,1.403,95%CI,1.007,2.143)、无病生存率(OR,1.233,95%CI1.011,1.714)和较少的癌症相关死亡(OR,0.282,95%CI 0.080,1.000),无论肿瘤分化如何,LCC患者似乎都有更好的肿瘤学结果。局限性:单中心回顾性研究,不排除遗传性癌症患者。肿瘤生物标志物并非在所有患者中都可用,也没有进行进一步的分析。
{"title":"Right versus left Colon cancer: Is there a difference in outcomes?","authors":"A. Plastiras, E. Iosif, G. Georgiou, A. Haji, Asif I Haq, S. Papagrigoriadis, J. Nunoo-Mensah","doi":"10.4103/WJCS.WJCS_31_18","DOIUrl":"https://doi.org/10.4103/WJCS.WJCS_31_18","url":null,"abstract":"Background: Colorectal cancer is a major healthcare problem due to its high prevalence and mortality rates. Objective: The objective of the study is to delineate the relationship between the location of the colon cancer and the outcomes. Design: This is a retrospective, single-center study including patients diagnosed with right and left colon cancer from January 2010 to December 2015. Setting: Patients with no rectal or synchronous metastatic disease were included in the study. Diagnosis was confirmed following a computed tomography and colonoscopy. Patients and Methods: Four hundred and seventy-five patients with colon cancer were included; 226 right-sided tumors (RCC) and 249 with left-sided colon cancer (LCC) underwent surgery. Main Outcome Measures: We compared right- and left-sided tumors in terms of epidemiological, histological, clinical, and perioperative characteristics, and we also attempted to determine whether there is a difference in the overall and per stage survival. Sample Size: Four hundred and seventy-five patients with colon cancer. Results: Patients with colon cancer were analyzed, 226 (47.5%) with RCC and 249 (52.4%) with LCC underwent surgery. Patients with RCC were more likely to be women, older, and with more comorbidities. Furthermore, RCC were more likely to be poorly differentiated (29.65%, P < 0.001) and more locally advanced at the time of diagnosis (P < 0.001). Controlling the differentiation for each stage, there was no statistical significant difference between left and right survival and recurrence (P > 0.05). When stratified according to tumor stage, Stage II LCC had better overall survival (odds ratio [OR], 1.694, 95% confidence interval [CI], 1.015, 2.827) and Stage III LCC had a better overall survival (OR, 1.403, 95% CI, 1.007, 2.143), disease-free survival (OR, 1.293, 95% CI, 1.011, 1.714), and less cancer-related deaths (OR, 0.282, 95% CI, 0.080, 1.000). Conclusions: Comparing similar stages, patients with LCC appear to have better oncological outcomes irrespective of tumor differentiation. Limitations: Single-center, retrospective study without excluding patients with hereditary cancers. Oncological biomarkers were not available in all patients, and further analysis was not performed.","PeriodicalId":90396,"journal":{"name":"World journal of colorectal surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49184150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the efficacy of biofeedback for chronic constipation using the constipation severity instrument and constipation-related quality of life measure 采用便秘严重程度量表和便秘相关生活质量量表评估生物反馈治疗慢性便秘的疗效
Pub Date : 2019-01-01 DOI: 10.4103/WJCS.WJCS_7_18
Y. Lan, Lillian G Jahan, M. Varma
Background: Many studies have described using biofeedback to treat chronic constipation, but few reports have addressed its impact on quality of life (QOL). Objective: The aim was to evaluate the effect of biofeedback with a validated Constipation Severity Instrument (CSI) and Constipation-Related QOL (CRQOL) measure. Design: Prospectively collected data with retrospective analysis. Setting: Tertiary care academic center. Patients and Methods: Patients referred to the Center for Pelvic Physiology with chronic constipation and objective signs of pelvic floor dyssynergia, who received a complete course of biofeedback therapy and returned all of their questionnaires, were enrolled in the study. Questionnaires were given upon initial evaluation, immediately after the complete course of biofeedback, and 6 months later. Main Outcome Measures: Improvement of dyssynergia symptom and QOL by CSI and CRQOL. Sample Size: A total of 25 patients (20 females and 5 males) were included. Results: Overall, 75% of patients reported satisfactory symptom and QOL improvement. CSI total scores decreased after treatment (35.0 vs. 31.0, P = 0.06) and at 6-month follow-up (35.0 vs. 30.0, P = 0.05). Only the obstructive defecation (OD) subscale of CSI improved significantly after treatment (median 21.0 vs. 16.5, P < 0.01) and sustained to 6 months after therapy (median 21.0 vs. 18.5, P = 0.03). Statistically significant improvement was seen in the distress subscale of the CRQOL immediately after biofeedback (24.0 vs. 18.0, P = 0.02). Conclusions: This study demonstrated that the active effects of biofeedback in constipated patients were specific to OD symptoms and the distress subscale for QOL. CSI and CRQOL are both useful tools to evaluate the specific response of constipated patients after biofeedback therapy. Limitations: The study limitation was the small sample size due to difficulty in obtaining complete information in the enrolled patients.
背景:许多研究描述了使用生物反馈治疗慢性便秘,但很少有报道涉及其对生活质量(QOL)的影响。目的:通过便秘严重程度量表(CSI)和便秘相关生活质量量表(CRQOL)评估生物反馈的效果。设计:前瞻性收集资料,回顾性分析。环境:三级医疗学术中心。患者和方法:在盆腔生理中心就诊的慢性便秘和盆底协同障碍客观症状的患者接受了完整的生物反馈治疗,并归还了所有的调查问卷。问卷分别在初始评估时、生物反馈完成疗程后和6个月后发放。主要观察指标:通过CSI和CRQOL来改善神经痛症状和生活质量。样本量:共纳入25例患者,其中女性20例,男性5例。结果:总体而言,75%的患者报告满意的症状和生活质量改善。治疗后CSI总分下降(35.0比31.0,P = 0.06),随访6个月时CSI总分下降(35.0比30.0,P = 0.05)。治疗后CSI中只有排便梗阻性(OD)亚量表显著改善(中位数21.0 vs. 16.5, P < 0.01),且持续至治疗后6个月(中位数21.0 vs. 18.5, P = 0.03)。生物反馈后CRQOL的痛苦分量表有统计学显著改善(24.0 vs. 18.0, P = 0.02)。结论:本研究表明,生物反馈对便秘患者的积极作用对OD症状和生活质量的困扰分量表具有特异性。CSI和CRQOL都是评价便秘患者生物反馈治疗后特异性反应的有用工具。局限性:研究的局限性在于样本量小,难以获得纳入患者的完整信息。
{"title":"Evaluating the efficacy of biofeedback for chronic constipation using the constipation severity instrument and constipation-related quality of life measure","authors":"Y. Lan, Lillian G Jahan, M. Varma","doi":"10.4103/WJCS.WJCS_7_18","DOIUrl":"https://doi.org/10.4103/WJCS.WJCS_7_18","url":null,"abstract":"Background: Many studies have described using biofeedback to treat chronic constipation, but few reports have addressed its impact on quality of life (QOL). Objective: The aim was to evaluate the effect of biofeedback with a validated Constipation Severity Instrument (CSI) and Constipation-Related QOL (CRQOL) measure. Design: Prospectively collected data with retrospective analysis. Setting: Tertiary care academic center. Patients and Methods: Patients referred to the Center for Pelvic Physiology with chronic constipation and objective signs of pelvic floor dyssynergia, who received a complete course of biofeedback therapy and returned all of their questionnaires, were enrolled in the study. Questionnaires were given upon initial evaluation, immediately after the complete course of biofeedback, and 6 months later. Main Outcome Measures: Improvement of dyssynergia symptom and QOL by CSI and CRQOL. Sample Size: A total of 25 patients (20 females and 5 males) were included. Results: Overall, 75% of patients reported satisfactory symptom and QOL improvement. CSI total scores decreased after treatment (35.0 vs. 31.0, P = 0.06) and at 6-month follow-up (35.0 vs. 30.0, P = 0.05). Only the obstructive defecation (OD) subscale of CSI improved significantly after treatment (median 21.0 vs. 16.5, P < 0.01) and sustained to 6 months after therapy (median 21.0 vs. 18.5, P = 0.03). Statistically significant improvement was seen in the distress subscale of the CRQOL immediately after biofeedback (24.0 vs. 18.0, P = 0.02). Conclusions: This study demonstrated that the active effects of biofeedback in constipated patients were specific to OD symptoms and the distress subscale for QOL. CSI and CRQOL are both useful tools to evaluate the specific response of constipated patients after biofeedback therapy. Limitations: The study limitation was the small sample size due to difficulty in obtaining complete information in the enrolled patients.","PeriodicalId":90396,"journal":{"name":"World journal of colorectal surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43375696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colon and rectal surgery for inflammatory bowel disease patients on vedolizumab: Preliminary surgical outcomes vedolizumab治疗炎症性肠病患者的结肠和直肠手术:初步手术结果
Pub Date : 2018-10-01 DOI: 10.4103/1941-8213.240252
S. Stringfield, Lisa A. Parry, S. Ramamoorthy, S. Eisenstein
Background and Objectives: Vedolizumab is an antagonist of leukocyte trafficking that targets gut α4β7 integrins and is efficacious in inflammatory bowel disease (IBD). Studies investigating postoperative complications in patients on this medication have not been performed. The objective of this study is to identify rates and types of postoperative complications experienced in patients with IBD who have undergone surgery following treatment with vedolizumab. Patients and Methods: This was a retrospective review of the electronic medical record of patients with IBD who underwent perianal or abdominal surgery, June 2014–March 2016, at the University of California San Diego Medical Center. Main outcome measures were rates and types of postoperative complications. Results: Patients were divided into three treatment groups: vedolizumab, other biologics, and no biologics. Twenty-nine patients on vedolizumab underwent forty operations that fit study criteria. Fifteen of 26 abdominal operations experienced a postoperative complication, for a complication rate of 57.7%. The most common complication was infectious (34.6%). Anastomotic leak rate was 16.7% and mortality rate was 7.7%. Complication rates in patients on vedolizumab were higher than rates in other patients with IBD. One of 14 perianal operations experienced an infectious complication (7%). Readmission rate in abdominal patients on vedolizumab was higher than the other categories (31% vs. 7% and 10%, P = 0.01). Conclusions: We observed high rates of postoperative complications in patients on vedolizumab who underwent abdominal surgery. Rates were higher than published outcomes as well as outcomes for other IBD patients at our institution. Studies including larger numbers of patients must be performed to further investigate this issue.
背景和目的:Vedolizumab是一种靶向肠道α4β7整合素的白细胞运输拮抗剂,对炎症性肠病(IBD)有效。研究调查术后并发症的患者使用这种药物尚未进行。本研究的目的是确定使用vedolizumab治疗后接受手术的IBD患者术后并发症的发生率和类型。患者和方法:这是对2014年6月至2016年3月在加州大学圣地亚哥医学中心接受肛周或腹部手术的IBD患者电子病历的回顾性分析。主要观察指标为术后并发症的发生率和类型。结果:患者分为三个治疗组:维多单抗、其他生物制剂和不使用生物制剂。29例vedolizumab患者接受了40例符合研究标准的手术。26例腹部手术中有15例出现术后并发症,并发症发生率为57.7%。最常见的并发症是感染(34.6%)。吻合口漏率为16.7%,死亡率为7.7%。vedolizumab组患者的并发症发生率高于其他IBD患者。14例肛周手术中有1例出现感染并发症(7%)。韦多单抗腹腔组患者再入院率高于其他组(31%比7%和10%,P = 0.01)。结论:我们观察到接受维多单抗的腹部手术患者术后并发症的发生率很高。该比率高于已发表的结果,也高于我们机构其他IBD患者的结果。为了进一步调查这一问题,必须进行包括大量患者在内的研究。
{"title":"Colon and rectal surgery for inflammatory bowel disease patients on vedolizumab: Preliminary surgical outcomes","authors":"S. Stringfield, Lisa A. Parry, S. Ramamoorthy, S. Eisenstein","doi":"10.4103/1941-8213.240252","DOIUrl":"https://doi.org/10.4103/1941-8213.240252","url":null,"abstract":"Background and Objectives: Vedolizumab is an antagonist of leukocyte trafficking that targets gut α4β7 integrins and is efficacious in inflammatory bowel disease (IBD). Studies investigating postoperative complications in patients on this medication have not been performed. The objective of this study is to identify rates and types of postoperative complications experienced in patients with IBD who have undergone surgery following treatment with vedolizumab. Patients and Methods: This was a retrospective review of the electronic medical record of patients with IBD who underwent perianal or abdominal surgery, June 2014–March 2016, at the University of California San Diego Medical Center. Main outcome measures were rates and types of postoperative complications. Results: Patients were divided into three treatment groups: vedolizumab, other biologics, and no biologics. Twenty-nine patients on vedolizumab underwent forty operations that fit study criteria. Fifteen of 26 abdominal operations experienced a postoperative complication, for a complication rate of 57.7%. The most common complication was infectious (34.6%). Anastomotic leak rate was 16.7% and mortality rate was 7.7%. Complication rates in patients on vedolizumab were higher than rates in other patients with IBD. One of 14 perianal operations experienced an infectious complication (7%). Readmission rate in abdominal patients on vedolizumab was higher than the other categories (31% vs. 7% and 10%, P = 0.01). Conclusions: We observed high rates of postoperative complications in patients on vedolizumab who underwent abdominal surgery. Rates were higher than published outcomes as well as outcomes for other IBD patients at our institution. Studies including larger numbers of patients must be performed to further investigate this issue.","PeriodicalId":90396,"journal":{"name":"World journal of colorectal surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47211415","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
#Colorectalsurgery: Connecting colorectal surgeons around the world #结直肠外科:连接世界各地的结直肠外科医生
Pub Date : 2018-10-01 DOI: 10.4103/1941-8213.240256
S. Emile, H. Elfeki
{"title":"#Colorectalsurgery: Connecting colorectal surgeons around the world","authors":"S. Emile, H. Elfeki","doi":"10.4103/1941-8213.240256","DOIUrl":"https://doi.org/10.4103/1941-8213.240256","url":null,"abstract":"","PeriodicalId":90396,"journal":{"name":"World journal of colorectal surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42961461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Back to basics – The importance of enterostomal therapy education for general surgery residents 回归基础-肠造口治疗教育对普外科住院医师的重要性
Pub Date : 2018-10-01 DOI: 10.4103/1941-8213.240253
John J. Tackett, Annabelle L. Fonseca, W. Longo
Background and Objectives: General surgery residents' perceived knowledge base and comfort with intestinal stomas and enterostomal therapy are profiled through a national survey. Subjects and Methods: General surgery residents were surveyed to explore the existence of formal didactics and training in ostomy creation and stomal care, to examine the residents' perceived knowledge base of clinical indications for enterostomal care approaches, and to elicit the residents' comfort with performing enterostomal surgeries and managing complications. Results: A total of 734 US residents were surveyed. 218 respondents completed the survey (30%): 40% Northeast, 22% Midwest, 22% South, 16% West, and 82% with direct university affiliation. Only 12% experienced formal enterostomal therapy training and only 15% attended related lectures. Most (86%) routinely worked with enterostomal therapists. Only 11% of chiefs felt “very confident” in their knowledge base of clinical indications for enterostomal care, and 61% felt “very comfortable” with surgical procedures of ostomy creation and closure. Merely 4% of all residents felt “very comfortable” dealing with common ostomy complications. Conclusions: In an era of surgical subspecialization and advanced nursing practice in enterostomal therapy, general surgery residents lack confidence in their knowledge base and comfort when approaching enterostomal therapy and stomal complications. US resident education should be reformed to enhance training in these fundamental principles essential to general surgery practice.
背景和目的:通过一项全国性调查,了解普通外科住院医师对肠造口和肠造口治疗的感知知识基础和舒适度。受试者和方法:对普通外科住院医师进行调查,以探索造口术创建和造口护理方面是否存在正式的教学和培训,检查住院医师对肠造口护理方法临床适应症的感知知识库,并引导住院医师对进行肠造口手术和管理并发症感到舒适。结果:共有734名美国居民接受了调查。218名受访者完成了这项调查(30%):40%为东北部,22%为中西部,22%为南部,16%为西部,82%为直接大学附属。只有12%的人接受过正式的肠造口治疗培训,只有15%的人参加过相关讲座。大多数人(86%)经常与肠造口治疗师合作。只有11%的酋长对他们的肠造口护理临床适应症知识库感到“非常有信心”,61%的酋长对造口术的创建和闭合手术程序感到“非常舒服”。只有4%的居民在处理常见的造口术并发症时感到“非常舒服”。结论:在肠造口治疗的外科亚专业化和高级护理实践时代,普通外科住院医师在处理肠造口治疗和造口并发症时,对自己的知识基础和舒适度缺乏信心。美国住院医师教育应该进行改革,以加强对这些基本原则的培训,这些原则对普通外科实践至关重要。
{"title":"Back to basics – The importance of enterostomal therapy education for general surgery residents","authors":"John J. Tackett, Annabelle L. Fonseca, W. Longo","doi":"10.4103/1941-8213.240253","DOIUrl":"https://doi.org/10.4103/1941-8213.240253","url":null,"abstract":"Background and Objectives: General surgery residents' perceived knowledge base and comfort with intestinal stomas and enterostomal therapy are profiled through a national survey. Subjects and Methods: General surgery residents were surveyed to explore the existence of formal didactics and training in ostomy creation and stomal care, to examine the residents' perceived knowledge base of clinical indications for enterostomal care approaches, and to elicit the residents' comfort with performing enterostomal surgeries and managing complications. Results: A total of 734 US residents were surveyed. 218 respondents completed the survey (30%): 40% Northeast, 22% Midwest, 22% South, 16% West, and 82% with direct university affiliation. Only 12% experienced formal enterostomal therapy training and only 15% attended related lectures. Most (86%) routinely worked with enterostomal therapists. Only 11% of chiefs felt “very confident” in their knowledge base of clinical indications for enterostomal care, and 61% felt “very comfortable” with surgical procedures of ostomy creation and closure. Merely 4% of all residents felt “very comfortable” dealing with common ostomy complications. Conclusions: In an era of surgical subspecialization and advanced nursing practice in enterostomal therapy, general surgery residents lack confidence in their knowledge base and comfort when approaching enterostomal therapy and stomal complications. US resident education should be reformed to enhance training in these fundamental principles essential to general surgery practice.","PeriodicalId":90396,"journal":{"name":"World journal of colorectal surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44665003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety of prone jackknife position in ambulatory anorectal surgery 俯卧刀位在门诊肛肠手术中的安全性
Pub Date : 2018-10-01 DOI: 10.4103/1941-8213.240255
F. Cheema, Sabair Lee, Marcus Zebrower, J. Poggio
Background and Objectives: The objectives of this study were to determine morbidity and mortality rates of ambulatory anorectal surgeries in prone jackknife position. Patients and Methods: Retrospective chart analysis on 210 patients undergoing ambulatory anorectal surgery in the prone jackknife position. The primary endpoint studied was mortality and complication rates. Other factors analyzed were age, sex, clinical diagnosis, procedure, past medical history, American Society of Anesthesiologists physical status classification, current smoking status, mean pre- and post-operative mean arterial pressure (MAP), mean minimum intraoperative MAP, minimum intraoperative O2saturation, estimated blood loss, fluids given, anesthesia duration, antibiotic administration, and days to discharge and whether there were any readmissions within 30 days. To assess significant differences between pre-, intra-, and post-operative mean arterial pressure, one-way ANOVA was used. Results: There was no mortality within 30 days of surgery. Complication rate was 3.3% with urinary retention being the most common, comprising 42% of all complications. Thirty-day readmission rate from surgery was 1%. Mean pre- and post-operative MAP was 88.4 ± 11.4 and 90.6 ± 11.9, respectively. Mean minimum intraoperative MAP and O2saturation was 70.6 ± 9.5 and 98.7% ± 1.6%, respectively. Mean minimum intraoperative MAP was significantly decreased compared to mean pre- and post-operative MAP (P < 0.05). Conclusion: Prone jackknife position supports the chest while relaxing the abdomen by flexing at the hips. In ambulatory anorectal surgeries under general anesthesia, given the hemodynamic stability and lack of intra- and post-operative complications, prone jackknife position is a noninferior alternative to supine or lithotomy position.
背景和目的:本研究的目的是确定俯卧位肛肠手术的发病率和死亡率。患者和方法:回顾性分析210例采用卧刀体位行门诊肛肠手术的患者。研究的主要终点是死亡率和并发症发生率。分析的其他因素包括年龄、性别、临床诊断、手术、既往病史、美国麻醉师学会身体状况分类、当前吸烟状况、术前和术后平均动脉压(MAP)、术中平均最低MAP、术中最低O2饱和度、估计失血量、给液量、麻醉持续时间、抗生素给药,出院天数以及30天内是否有再次入院。为了评估术前、术中和术后平均动脉压之间的显著差异,使用了单因素方差分析。结果:术后30天内无死亡病例。并发症发生率为3.3%,其中尿潴留最为常见,占所有并发症的42%。术后30天再次入院率为1%。术前和术后平均MAP分别为88.4±11.4和90.6±11.9。术中平均最低MAP和O2饱和度分别为70.6±9.5和98.7%±1.6%。与术前和术后平均MAP相比,术中平均最小MAP显著降低(P<0.05)。结论:俯卧位支撑胸部,同时通过弯曲臀部放松腹部。在全麻下的门诊肛肠手术中,考虑到血液动力学的稳定性以及术中和术后并发症的减少,俯卧位是仰卧位或取石位的一种非劣性选择。
{"title":"Safety of prone jackknife position in ambulatory anorectal surgery","authors":"F. Cheema, Sabair Lee, Marcus Zebrower, J. Poggio","doi":"10.4103/1941-8213.240255","DOIUrl":"https://doi.org/10.4103/1941-8213.240255","url":null,"abstract":"Background and Objectives: The objectives of this study were to determine morbidity and mortality rates of ambulatory anorectal surgeries in prone jackknife position. Patients and Methods: Retrospective chart analysis on 210 patients undergoing ambulatory anorectal surgery in the prone jackknife position. The primary endpoint studied was mortality and complication rates. Other factors analyzed were age, sex, clinical diagnosis, procedure, past medical history, American Society of Anesthesiologists physical status classification, current smoking status, mean pre- and post-operative mean arterial pressure (MAP), mean minimum intraoperative MAP, minimum intraoperative O2saturation, estimated blood loss, fluids given, anesthesia duration, antibiotic administration, and days to discharge and whether there were any readmissions within 30 days. To assess significant differences between pre-, intra-, and post-operative mean arterial pressure, one-way ANOVA was used. Results: There was no mortality within 30 days of surgery. Complication rate was 3.3% with urinary retention being the most common, comprising 42% of all complications. Thirty-day readmission rate from surgery was 1%. Mean pre- and post-operative MAP was 88.4 ± 11.4 and 90.6 ± 11.9, respectively. Mean minimum intraoperative MAP and O2saturation was 70.6 ± 9.5 and 98.7% ± 1.6%, respectively. Mean minimum intraoperative MAP was significantly decreased compared to mean pre- and post-operative MAP (P < 0.05). Conclusion: Prone jackknife position supports the chest while relaxing the abdomen by flexing at the hips. In ambulatory anorectal surgeries under general anesthesia, given the hemodynamic stability and lack of intra- and post-operative complications, prone jackknife position is a noninferior alternative to supine or lithotomy position.","PeriodicalId":90396,"journal":{"name":"World journal of colorectal surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49260813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Mucosal advancement flap for fistula-in-ano: A single-institution experience 粘膜推进皮瓣治疗瘘管:单一机构的经验
Pub Date : 2018-10-01 DOI: 10.4103/1941-8213.240254
Y. Kaneko, D. Lam, J. Keck, R. Woods
Background and Objective: Mucosal advancement flap (MAF) is a well-described definitive treatment for complex fistula-in-ano, with high healing rates ranging from 37 to 87% for cryptoglandular fistula, but with mild incontinence rates of up to 35%. There is a paucity of Australian data to support the efficacy and complication rates of MAF, nor predictive factors for success. Patients and Methods: This was a retrospective study, with ethical approval granted by St. Vincent's Hospital Melbourne (SVHM) Quality and Risk Unit. Patients who underwent MAF at SVHM and St Vincent's Private Hospital Fitzroy from 2011 to 2015 were included in the study; all data were collected from patient medical records. Results: A total of 65 patients were treated with MAF during the study period. Fistula etiology was cryptoglandular in 82%, anovaginal in 11%, and perianal Crohn's disease in 7% of patients. Overall success rates for MAF were 66% for cryptoglandular fistula, 14% for anovaginal fistula, and 40% for Crohn's fistula. Excluding anovaginal fistulae, the success rate of MAF was 74% for males and 57% for females. MAF performed for an anterior internal opening was associated with a success rate of 65% versus 56% for a posterior internal opening. Postoperative fecal incontinence rate was 6%. Five of the patients with failed MAF underwent a second sphincter-preserving procedure; none of these were successful. Conclusion: This study supports the use of MAF for the treatment of complex fistula-in-ano, with a success rate compatible with existing literature and a low incontinence rate.
背景和目的:粘膜推进皮瓣(MAF)是一种公认的治疗肛门复杂瘘的确切方法,隐腺瘘的治愈率高达37%至87%,但轻度失禁率高达35%。澳大利亚缺乏支持MAF疗效和并发症发生率的数据,也没有成功的预测因素。患者和方法:这是一项回顾性研究,获得了墨尔本圣文森特医院(SVHM)质量和风险部门的伦理批准。2011年至2015年在菲茨罗伊SVHM和圣文森特私立医院接受MAF的患者被纳入研究;所有数据均来自患者病历。结果:在研究期间,共有65名患者接受了MAF治疗。瘘管病因为隐腺性占82%,无阴道性占11%,肛周克罗恩病占7%。隐腺瘘MAF的总成功率为66%,无阴道瘘为14%,克罗恩氏瘘为40%。除无阴道瘘外,MAF的成功率男性为74%,女性为57%。对前部内部开口进行MAF与65%的成功率相关,而对后部内部开口进行的成功率为56%。术后大便失禁发生率为6%。其中5名MAF失败的患者接受了第二次括约肌保留手术;这些都没有成功。结论:本研究支持MAF治疗肛门复杂瘘,其成功率与现有文献一致,失禁率较低。
{"title":"Mucosal advancement flap for fistula-in-ano: A single-institution experience","authors":"Y. Kaneko, D. Lam, J. Keck, R. Woods","doi":"10.4103/1941-8213.240254","DOIUrl":"https://doi.org/10.4103/1941-8213.240254","url":null,"abstract":"Background and Objective: Mucosal advancement flap (MAF) is a well-described definitive treatment for complex fistula-in-ano, with high healing rates ranging from 37 to 87% for cryptoglandular fistula, but with mild incontinence rates of up to 35%. There is a paucity of Australian data to support the efficacy and complication rates of MAF, nor predictive factors for success. Patients and Methods: This was a retrospective study, with ethical approval granted by St. Vincent's Hospital Melbourne (SVHM) Quality and Risk Unit. Patients who underwent MAF at SVHM and St Vincent's Private Hospital Fitzroy from 2011 to 2015 were included in the study; all data were collected from patient medical records. Results: A total of 65 patients were treated with MAF during the study period. Fistula etiology was cryptoglandular in 82%, anovaginal in 11%, and perianal Crohn's disease in 7% of patients. Overall success rates for MAF were 66% for cryptoglandular fistula, 14% for anovaginal fistula, and 40% for Crohn's fistula. Excluding anovaginal fistulae, the success rate of MAF was 74% for males and 57% for females. MAF performed for an anterior internal opening was associated with a success rate of 65% versus 56% for a posterior internal opening. Postoperative fecal incontinence rate was 6%. Five of the patients with failed MAF underwent a second sphincter-preserving procedure; none of these were successful. Conclusion: This study supports the use of MAF for the treatment of complex fistula-in-ano, with a success rate compatible with existing literature and a low incontinence rate.","PeriodicalId":90396,"journal":{"name":"World journal of colorectal surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45878581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PELVIC FLOOR SYMPTOMS AND QUALITY OF LIFE ANALYSES IN WOMEN UNDERGOING SURGERY FOR RECTAL PROLPASE. 接受直肠脱垂酶手术的妇女盆底症状和生活质量分析
Pub Date : 2013-12-01
Dr Ellington, M Mann, Cb Bowling, Er Drelichman, Wj Greer, Jm Szychowski, He Richter

Objective: Characterize pelvic floor symptom distress and impact, sexual function and quality of life in women who underwent rectal prolapse surgery.

Methods: Subjects undergoing rectal prolapse surgery from 2004-2009 completed questionnaires including the Pelvic Floor Distress Inventory, Pelvic Floor Impact Questionnaire, and the Prolapse/Urinary Incontinence Sexual Questionnaire. Baseline demographic, medical, and surgical characteristics were extracted by chart review. Demographic and clinic outcomes of women undergoing transperineal and abdominal approaches were compared. Wilcoxon rank-sum test was used for continuous variables and Fisher's exact test for categorical measures.

Results: 45 were identified; two deceased at follow-up. 28/43 subjects (65.1%) responded to the questionnaires. Mean time from original procedure was 3.9 ± 3.1 years. No differences in median total Pelvic Floor Distress Inventory, Pelvic Floor Impact Questionnaire, and subscale scores, and Prolapse/Urinary Incontinence Sexual Questionnaire scores in women undergoing open rectopexy versus transperineal proctectomy were seen (all p>0.05). 26 (60%) participants answered the Prolapse/Urinary Incontinence Sexual Questionnaire, nine reported sexual activity within the last month. All underwent abdominal procedures.

Conclusion: There are few colorectal or other pelvic floor symptoms after rectal prolapse repair. Robust prospective studies are needed to more fully characterize and understand issues associated with rectal prolapse surgery in women.

目的:探讨接受直肠脱垂手术的妇女盆底症状、困扰和影响、性功能和生活质量。方法:2004-2009年接受直肠脱垂手术的患者填写盆底困扰问卷、盆底冲击问卷和脱垂/尿失禁性问卷。通过图表回顾提取基线人口统计学、医学和外科特征。比较经会阴入路和腹部入路妇女的人口学和临床结果。连续变量采用Wilcoxon秩和检验,分类测量采用Fisher精确检验。结果:共鉴定出45例;随访时2例死亡。43名受试者中有28人(65.1%)回复了问卷。术后平均时间为3.9±3.1年。盆底窘迫量表、盆底冲击问卷和亚量表评分中位数以及脱垂/尿失禁性问卷评分在开腹直肠切除术和经会阴直肠直肠切除术妇女中均无差异(均p>0.05)。26名(60%)参与者回答了脱垂/尿失禁性问卷,9名报告了上个月的性行为。所有患者均接受了腹部手术。结论:直肠脱垂修复术后很少出现结直肠或其他盆底症状。需要强有力的前瞻性研究来更充分地描述和理解与女性直肠脱垂手术相关的问题。
{"title":"PELVIC FLOOR SYMPTOMS AND QUALITY OF LIFE ANALYSES IN WOMEN UNDERGOING SURGERY FOR RECTAL PROLPASE.","authors":"Dr Ellington,&nbsp;M Mann,&nbsp;Cb Bowling,&nbsp;Er Drelichman,&nbsp;Wj Greer,&nbsp;Jm Szychowski,&nbsp;He Richter","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>Characterize pelvic floor symptom distress and impact, sexual function and quality of life in women who underwent rectal prolapse surgery.</p><p><strong>Methods: </strong>Subjects undergoing rectal prolapse surgery from 2004-2009 completed questionnaires including the Pelvic Floor Distress Inventory, Pelvic Floor Impact Questionnaire, and the Prolapse/Urinary Incontinence Sexual Questionnaire. Baseline demographic, medical, and surgical characteristics were extracted by chart review. Demographic and clinic outcomes of women undergoing transperineal and abdominal approaches were compared. Wilcoxon rank-sum test was used for continuous variables and Fisher's exact test for categorical measures.</p><p><strong>Results: </strong>45 were identified; two deceased at follow-up. 28/43 subjects (65.1%) responded to the questionnaires. Mean time from original procedure was 3.9 ± 3.1 years. No differences in median total Pelvic Floor Distress Inventory, Pelvic Floor Impact Questionnaire, and subscale scores, and Prolapse/Urinary Incontinence Sexual Questionnaire scores in women undergoing open rectopexy versus transperineal proctectomy were seen (all p>0.05). 26 (60%) participants answered the Prolapse/Urinary Incontinence Sexual Questionnaire, nine reported sexual activity within the last month. All underwent abdominal procedures.</p><p><strong>Conclusion: </strong>There are few colorectal or other pelvic floor symptoms after rectal prolapse repair. Robust prospective studies are needed to more fully characterize and understand issues associated with rectal prolapse surgery in women.</p>","PeriodicalId":90396,"journal":{"name":"World journal of colorectal surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219513/pdf/nihms567599.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32799989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subsequent Adenomas of Ileal Pouch and Anorectal Segment after Prophylactic Surgery for Familial Adenomatous Polyposis. 家族性腺瘤性息肉病预防性手术后回肠袋及肛肠段继发性腺瘤。
Pub Date : 2013-01-01
A E M'Koma, A J Herline, S E Adunyah

Familial adenomatous polyposis (FAP) is an autosomally dominant disease characterized by the early development of colorectal adenomas and carcinoma in untreated patients. Patients with FAP may develop rectal cancer at their initial presentation (primary) or after prophylactic surgery (secondary). Controversies exist regarding which surgical procedure represents the best first-line treatment. The options for FAP are ileorectal anastomosis (IRA) or a restorative proctocolectomy (RPC) with either a handsewn or a stapled ileal pouch-anal anastomosis (IPAA), with or without mucosectomy. The purpose of these surgeries is to stop progression to an adenoma-cancer sequence by eradicating the colon, a disease prone organ. Unfortunately, these surgical procedures, which excise the entire colon and rectum while maintaining transanal fecal continence, do not guarantee that patients still won't develop adenomas. Based on the available literature, we therefore reviewed reported incidences of pouch-related adenomas that occurred post prophylactic surgery for FAP. The review consists of a collection of case, descriptive, prospective and retrospective reports.

Objectives: To provide available data on the natural history of subsequent adenomas after prophylactic surgery (by type) for FAP.

Methods: A review was conducted of existing case, descriptive, prospective and retrospective reports for patients undergoing prophylactic surgery for FAP (1975 - August, 2013). In each case, the adenomas were clearly diagnosed in one of the following: the ileal pouch mucosa (above the ileorectal anastomosis), within the anorectal segment (ARS) below the ileorectal anastomosis, or in the afferent ileal loop.

Results: A total of 515 (36%) patients with pouch-related adenomas have been reported. Two hundred and eleven (211) patients had adenomas in the ileal pouch mucosa, 295 had them in the ARS and in 9 were in the afferent ileal loop. Patients with pouch adenomas without dysplasia or cancer were either endoscopically polypectomized or were treated with a coagulation modality using either a Nd:Yag laser or argon plasma coagulation (as indicated). Patients with dysplastic pouch adenomas or pouch adenomas with cancer had their pouch excised (pouchectomy).

Conclusion: In patients with FAP treated with IRA or RPC with IPAA, the formation of adenomas in the pouch-body mucosa or ARS/anastomosis and in the afferent ileal loop is apparent. Because of risks for adenoma recurrence, a life time endoscopic pouch-surveillance is warranted.

家族性腺瘤性息肉病(FAP)是一种常染色体显性疾病,其特征是未经治疗的患者早期发展为结直肠腺瘤和癌。FAP患者可能在其最初表现(原发性)或预防性手术(继发性)后发展为直肠癌。关于哪种外科手术是最好的一线治疗存在争议。FAP的选择是回肠直肠吻合术(IRA)或修复性直结肠切除术(RPC),采用手工缝合或缝合回肠袋-肛门吻合术(IPAA),伴或不伴粘膜切除术。这些手术的目的是通过根除结肠(一个易患病的器官)来阻止腺瘤-癌症的发展。不幸的是,这些外科手术切除了整个结肠和直肠,同时保持了经肛门的大便失禁,并不能保证患者不会患上腺瘤。基于现有文献,我们回顾了FAP预防性手术后发生的袋相关腺瘤的发生率。审查包括收集病例、描述性、前瞻性和回顾性报告。目的:提供FAP预防性手术(按类型)后腺瘤自然病史的可用数据。方法:对1975年至2013年8月接受FAP预防性手术的现有病例、描述性、前瞻性和回顾性报告进行回顾性分析。在每个病例中,腺瘤明确诊断在以下一种:回肠袋粘膜(在回直肠吻合处上方),在回肠吻合处下方的肛肠段(ARS)内,或回肠传入袢内。结果:共报道515例(36%)袋相关腺瘤患者。211例(211例)回肠小袋粘膜腺瘤,295例发生在回肠回袢,9例发生在回肠进袢。没有发育不良或癌症的眼袋腺瘤患者要么在内镜下切除息肉,要么采用Nd:Yag激光或氩等离子凝固治疗(如所示)。患有发育不良的眼袋腺瘤或癌性眼袋腺瘤的患者均行眼袋切除术。结论:应用IRA或RPC联合IPAA治疗FAP时,囊体黏膜、ARS/吻合口及回肠进袢腺瘤形成明显。由于腺瘤复发的风险,终身内镜袋监测是必要的。
{"title":"Subsequent Adenomas of Ileal Pouch and Anorectal Segment after Prophylactic Surgery for Familial Adenomatous Polyposis.","authors":"A E M'Koma,&nbsp;A J Herline,&nbsp;S E Adunyah","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Familial adenomatous polyposis (FAP) is an autosomally dominant disease characterized by the early development of colorectal adenomas and carcinoma in untreated patients. Patients with FAP may develop rectal cancer at their initial presentation (primary) or after prophylactic surgery (secondary). Controversies exist regarding which surgical procedure represents the best first-line treatment. The options for FAP are ileorectal anastomosis (IRA) or a restorative proctocolectomy (RPC) with either a handsewn or a stapled ileal pouch-anal anastomosis (IPAA), with or without mucosectomy. The purpose of these surgeries is to stop progression to an adenoma-cancer sequence by eradicating the colon, a disease prone organ. Unfortunately, these surgical procedures, which excise the entire colon and rectum while maintaining transanal fecal continence, do not guarantee that patients still won't develop adenomas. Based on the available literature, we therefore reviewed reported incidences of pouch-related adenomas that occurred post prophylactic surgery for FAP. The review consists of a collection of case, descriptive, prospective and retrospective reports.</p><p><strong>Objectives: </strong>To provide available data on the natural history of subsequent adenomas after prophylactic surgery (by type) for FAP.</p><p><strong>Methods: </strong>A review was conducted of existing case, descriptive, prospective and retrospective reports for patients undergoing prophylactic surgery for FAP (1975 - August, 2013). In each case, the adenomas were clearly diagnosed in one of the following: the ileal pouch mucosa (above the ileorectal anastomosis), within the anorectal segment (ARS) below the ileorectal anastomosis, or in the afferent ileal loop.</p><p><strong>Results: </strong>A total of 515 (36%) patients with pouch-related adenomas have been reported. Two hundred and eleven (211) patients had adenomas in the ileal pouch mucosa, 295 had them in the ARS and in 9 were in the afferent ileal loop. Patients with pouch adenomas without dysplasia or cancer were either endoscopically polypectomized or were treated with a coagulation modality using either a Nd:Yag laser or argon plasma coagulation (as indicated). Patients with dysplastic pouch adenomas or pouch adenomas with cancer had their pouch excised (pouchectomy).</p><p><strong>Conclusion: </strong>In patients with FAP treated with IRA or RPC with IPAA, the formation of adenomas in the pouch-body mucosa or ARS/anastomosis and in the afferent ileal loop is apparent. Because of risks for adenoma recurrence, a life time endoscopic pouch-surveillance is warranted.</p>","PeriodicalId":90396,"journal":{"name":"World journal of colorectal surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012278/pdf/nihms-575932.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32333996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LOCAL GLYCERYL TRINITRATE VERSUS LATERAL INTERNAL SPHINCTEROTOMY IN MANAGEMENT OF ANAL FISSURE 局部三硝酸甘油与外侧内括约肌切开术治疗肛裂
Pub Date : 2009-12-31 DOI: 10.5580/240a
G. Ellabban, galal elkazaz, emad hokam
Introduction: Anal fissure is a common benign condition that can cause severe anal pain after defecation and bleeding. Symptoms from fissure cause considerable morbidity and reduction in quality of life. The aim of treatment is to reduce anal hvpertonia, which may improve anodermal blood flow and heal the fissure. Aim of the work: This study aimed to evaluate the effectiveness of local glyceryl trinitrate (GTN) versus surgical lateral internal sphincterotomy in the management of acute and chronic anal fissure. Patients and methods: In our present study we compared topical application of GTN on lipsomal base with the surgical procedure i.e. internal lateral sphincterotomy and according to the method of treatment the patients were divided into two groups; group 1 which included 40 patients with anal fissure and agreed to have the medical treatment with topical GTN 0.2% applied to the anoderm twice daily. Group 2 also included 40 patients and treated with lateral internal
简介:肛裂是一种常见的良性疾病,可引起排便后严重的肛门疼痛和出血。裂缝的症状引起相当大的发病率和生活质量的降低。治疗的目的是减少肛门高渗,这可能会改善非正常血液流动和愈合裂缝。工作目的:本研究旨在评估局部三硝酸甘油(GTN)与手术外侧内括约肌切开术治疗急慢性肛裂的有效性。患者和方法:本研究比较了GTN在脂体基础上的局部应用与手术治疗,即内外侧括约肌切开术,并根据治疗方法将患者分为两组;第一组为40例肛裂患者,同意每日两次在肛肠外用0.2% GTN进行治疗。组2也包括40例患者,采用外侧内窥镜治疗
{"title":"LOCAL GLYCERYL TRINITRATE VERSUS LATERAL INTERNAL SPHINCTEROTOMY IN MANAGEMENT OF ANAL FISSURE","authors":"G. Ellabban, galal elkazaz, emad hokam","doi":"10.5580/240a","DOIUrl":"https://doi.org/10.5580/240a","url":null,"abstract":"Introduction: Anal fissure is a common benign condition that can cause severe anal pain after defecation and bleeding. Symptoms from fissure cause considerable morbidity and reduction in quality of life. The aim of treatment is to reduce anal hvpertonia, which may improve anodermal blood flow and heal the fissure. Aim of the work: This study aimed to evaluate the effectiveness of local glyceryl trinitrate (GTN) versus surgical lateral internal sphincterotomy in the management of acute and chronic anal fissure. Patients and methods: In our present study we compared topical application of GTN on lipsomal base with the surgical procedure i.e. internal lateral sphincterotomy and according to the method of treatment the patients were divided into two groups; group 1 which included 40 patients with anal fissure and agreed to have the medical treatment with topical GTN 0.2% applied to the anoderm twice daily. Group 2 also included 40 patients and treated with lateral internal","PeriodicalId":90396,"journal":{"name":"World journal of colorectal surgery","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2009-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70819102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
期刊
World journal of colorectal surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1